Pages that link to "Q38044739"

The following pages link to Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. (Q38044739):

Displaying 49 items.

• The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance (Q21089782) (← links)
• Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry (Q26745094) (← links)
• Antimicrobial bacteriophage-derived proteins and therapeutic applications (Q26781115) (← links)
• Escherichia coli in Europe: an overview (Q27015697) (← links)
• Antibiotic alternatives: the substitution of antibiotics in animal husbandry? (Q27027984) (← links)
• Structure of bacteriophage SPN1S endolysin reveals an unusual two-module fold for the peptidoglycan lytic and binding activity (Q27689555) (← links)
• Bacteriophages and phage-derived proteins--application approaches (Q28082731) (← links)
• GMEnzy: a genetically modified enzybiotic database (Q28541518) (← links)
• Effective removal of staphylococcal biofilms by the endolysin LysH5. (Q34156197) (← links)
• Potential of the virion-associated peptidoglycan hydrolase HydH5 and its derivative fusion proteins in milk biopreservation. (Q34566563) (← links)
• Core and accessory genome architecture in a group of Pseudomonas aeruginosa Mu-like phages. (Q35228812) (← links)
• Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent (Q35653429) (← links)
• A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability (Q35808669) (← links)
• Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity (Q35842148) (← links)
• Isolation and Genome Characterization of the Virulent Staphylococcus aureus Bacteriophage SA97. (Q36246630) (← links)
• Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process (Q37737552) (← links)
• New perspectives in the management of Pseudomonas aeruginosa infections (Q38243221) (← links)
• Phage lytic proteins: biotechnological applications beyond clinical antimicrobials. (Q38325227) (← links)
• Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria (Q38392069) (← links)
• Biological roles of glycans (Q38936714) (← links)
• Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128. (Q40192368) (← links)
• Bacteriophage therapy for membrane biofouling in membrane bioreactors and antibiotic-resistant bacterial biofilms (Q41329193) (← links)
• EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis (Q41457130) (← links)
• Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections (Q41484363) (← links)
• The peptidoglycan hydrolase of Staphylococcus aureus bacteriophage 11 plays a structural role in the viral particle (Q42068372) (← links)
• Properties and mutation studies of a bacteriophage-derived chimeric recombinant staphylolytic protein P128: Comparison to recombinant lysostaphin (Q42126654) (← links)
• Lysogenic conversion and phage resistance development in phage exposed Escherichia coli biofilms (Q42277772) (← links)
• Genome analysis of the staphylococcal temperate phage DW2 and functional studies on the endolysin and tail hydrolase (Q42773690) (← links)
• Bacteriophage-Derived Peptidase CHAP(K) Eliminates and Prevents Staphylococcal Biofilms (Q43245858) (← links)
• Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies. (Q46251747) (← links)
• Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue (Q47104261) (← links)
• Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy? (Q47114256) (← links)
• Genomic characterization of key bacteriophages to formulate the potential biocontrol agent to combat enteric pathogenic bacteria (Q47718472) (← links)
• Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus? (Q48181608) (← links)
• Antimicrobial Resistance: Its Surveillance, Impact, and Alternative Management Strategies in Dairy Animals. (Q48513977) (← links)
• Alternatives to antibiotics in poultry feed: molecular perspectives (Q49941593) (← links)
• Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials. (Q52642775) (← links)
• Bacteriophages: Protagonists of a Post-Antibiotic Era (Q56888912) (← links)
• Application of Bacteriophages in the Agro-Food Sector: A Long Way Toward Approval (Q58719447) (← links)
• Antibacterial Activity of a Lytic Enzyme Encoded by Double Stranded RNA Bacteriophage phiYY (Q58801468) (← links)
• Genomic analysis and immune response in a murine mastitis model of vB_EcoM-UFV13, a potential biocontrol agent for use in dairy cows (Q59349072) (← links)
• Enzymes and Mechanisms Employed by Tailed Bacteriophages to Breach the Bacterial Cell Barriers (Q59355700) (← links)
• More than rotating flagella: LPS as a secondary receptor for flagellotropic phage 7-7-1 (Q59356823) (← links)
• Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy (Q59360275) (← links)
• Broad Bactericidal Activity of the Bacteriophage Lysins LysAm24, LysECD7, and LysSi3 against Gram-Negative ESKAPE Pathogens (Q64068310) (← links)
• Genomic analyses of two novel biofilm-degrading methicillin-resistant Staphylococcus aureus phages. (Q64904151) (← links)
• Structural and functional insights into a novel two-component endolysin encoded by a single gene in Enterococcus faecalis phage (Q90356758) (← links)
• Expanding the Diversity of Myoviridae Phages Infecting Lactobacillus plantarum-A Novel Lineage of Lactobacillus Phages Comprising Five New Members (Q91658155) (← links)
• Characterization of extended-spectrum-β-lactamase producing Klebsiella pneumoniae phage KP1801 and evaluation of therapeutic efficacy in vitro and in vivo (Q97549455) (← links)